Liberty Star Uranium & Metals (LBSR) 10-Q 21 Jun 21 2022 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Apr. 30, 2021	Jun. 21, 2021
Cover [Abstract]
Entity Registrant Name	LIBERTY STAR URANIUM & METALS CORP.
Entity Central Index Key	0001172178
Document Type	10-Q
Document Period End Date	Apr. 30, 2021
Amendment Flag	false
Current Fiscal Year End Date	--01-31
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business Flag	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		10,150,635
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2022

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Apr. 30, 2021	Jan. 31, 2021
Current:
Cash and cash equivalents	$ 126,882	$ 6,718
Prepaid expenses	6,178	4,815
Total current assets	133,060	11,533
Property and equipment, net	32,097	33,556
Total assets	165,157	45,089
Current:
Accounts payable and accrued liabilities	470,355	467,957
Accounts payable to related parties	51,119	51,119
Accrued wages to related parties	811,711	811,711
Advances from related party	314,742	301,077
Notes payable to related parties	298,064	283,271
Convertible promissory note, net of debt discount of $51,425 and $7,642	84,176	87,969
Derivative liability	290,293
Total current liabilities	2,320,460	2,003,104
Long-term:
Long-term accounts payable, net of current portion	13,800	20,300
Long-term debt - SBA	66,020	33,162
Total long-term liabilities	79,820	53,462
Total liabilities	2,400,280	2,056,566
Commitments and Contingencies (Note 13)
Stockholders' deficit
Common stock value	101	99
Common stock to be issued		15,000
Additional paid-in capital	55,376,540	55,503,564
Accumulated deficit	(57,611,765)	(57,530,141)
Total stockholders' deficit	(2,235,123)	(2,011,477)
Total liabilities and stockholders' deficit	165,157	45,089
Class A Common Stock [Member]
Stockholders' deficit
Common stock value	$ 1	$ 1

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Apr. 30, 2021	Jan. 31, 2021
Convertible promissory note, debt discount	$ 51,425	$ 7,642
Common stock, par value	$ 0.00001	$ 0.00001
Common stock, shares authorized	12,300,000	12,300,000
Common stock, shares issued	10,052,163	9,902,052
Common stock, shares outstanding	10,052,163	9,902,052
Class A Common Stock [Member]
Common stock, par value	$ 0.00001	$ 0.00001
Common stock, shares authorized	200,000	0
Common stock, shares issued	102,000	0
Common stock, shares outstanding	102,000	0

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Apr. 30, 2021	Apr. 30, 2020
Income Statement [Abstract]
Revenues
Expenses:
Geological and geophysical costs	1,759	2,958
Salaries and benefits	36,559	37,750
Depreciation	1,458	1,674
Legal	19,947	50,536
Professional services	20,337	19,956
General and administrative	13,392	19,961
Travel	640	439
Net operating expenses	94,092	133,274
Loss from operations	(94,092)	(133,274)
Other income (expense):
Interest expense	(38,184)	(105,503)
Gain on change in fair value of derivative liability	50,652	55,036
Total other income (expense)	12,468	(50,467)
Net loss	$ (81,624)	$ (183,741)
Net loss per share of common stock - basic and diluted	$ (0.01)	$ (0.02)
Weighted average number of shares of common stock outstanding - basic and diluted	10,041,420	9,256,178

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)	Class A Common Stock [Member]	Common Stock [Member]	Stock Subscription Receivable [Member]	Common Stock to be Issued [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Total
Beginning Balance at Jan. 31, 2020		$ 91			$ 55,074,257	$ (56,780,396)	$ (1,706,048)
Beginning Balance, shares at Jan. 31, 2020		9,116,725
Issuance of common stock and warrants in private placement and warrant exercises		$ 1			20,598		20,599
Issuance of common stock and warrants in private placement and warrant exercises, shares		54,000
Shares issued for conversion of notes		$ 4			106,796		106,800
Shares issued for conversion of notes, shares		390,481
Reclass of APIC to derivative liabilities for tainted warrants					(189,472)		(189,472)
Resolution of derivative liabilities due to debt conversions					106,514		106,514
Net loss						(183,741)	(183,741)
Ending Balance at Apr. 30, 2020		$ 96			55,118,693	(56,964,137)	(1,845,348)
Ending Balance, shares at Apr. 30, 2020		9,561,206
Beginning Balance at Jan. 31, 2021	$ 1	$ 99		15,000	55,503,564	(57,530,141)	(2,011,477)
Beginning Balance, shares at Jan. 31, 2021	102,000	9,902,052
Issuance of common stock and warrants in private placement and warrant exercises		$ 1		(15,000)	122,099		107,100
Issuance of common stock and warrants in private placement and warrant exercises, shares		116,230
Shares issued for conversion of notes		$ 1			26,999		27,000
Shares issued for conversion of notes, shares		33,881
Reclass of APIC to derivative liabilities for tainted warrants					(293,528)		(293,528)
Resolution of derivative liabilities due to debt conversions					17,406		17,406
Net loss						(81,624)	(81,624)
Ending Balance at Apr. 30, 2021	$ 1	$ 101			$ 55,376,540	$ (57,611,765)	$ (2,235,123)
Ending Balance, shares at Apr. 30, 2021	102,000	10,052,163

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Apr. 30, 2021	Apr. 30, 2020
Cash flows from operating activities:
Net loss	$ (81,624)	$ (183,741)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	1,458	1,674
Amortization of debt discounts	23,306	98,568
Gain on change in fair value of derivative liabilities	(50,652)	(55,036)
Changes in assets and liabilities:
Prepaid expenses	(1,363)	(3,899)
Accounts payable and accrued expenses	18,274	31,526
Accrued interest	11,167	6,936
Cash flows used in operating activities:	(79,433)	(103,972)
Cash flows from financing activities:
Proceeds from notes payable	32,497
Cash advance from related party		10,000
Proceeds from notes payable, related parties		55,000
Proceeds from convertible promissory notes	60,000
Proceeds from the issuance of common stock and warrants	105,000	20,599
Proceeds from exercise of warrants	2,100
Net cash provided by financing activities	199,597	85,599
Increase (decrease) in cash and cash equivalents	120,164	(18,373)
Cash and cash equivalents, beginning of period	6,718	25,024
Cash and cash equivalents, end of period	126,882	6,651
Supplemental disclosure of cash flow information:
Income tax paid
Interest paid
Supplemental disclosure of non-cash items:
Resolution of derivative liabilities due to debt conversions and untainted warrants	17,406	106,514
Reclass of APIC to derivative liabilities for tainted warrants	293,528	189,472
Debt discounts due to derivative liabilities	64,823	107,000
Common stock issued for conversion of debt and interest	27,000	106,800
Expenses paid by related party on behalf of the Company	$ 22,376	$ 30,690

Basis of Presentation

Basis of Presentation	3 Months Ended
	Apr. 30, 2021
Accounting Policies [Abstract]
Basis of Presentation	NOTE 1 – Basis of Presentation The consolidated financial statements included herein have been prepared by Liberty Star Uranium & Metals Corp. (the “Company”, “we”, “our”) without audit, pursuant to the rules and regulations of the United States Securities and Exchange Commission (“SEC”) and should be read in conjunction with our annual report on Form 10-K for the year ended January 31, 2021 as filed with the SEC under the Securities and Exchange Act of 1934 (the “Exchange Act”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted, as permitted by the SEC, although we believe the disclosures which are made are adequate to make the information presented not misleading. The consolidated financial statements reflect, in the opinion of management, all normal recurring adjustments necessary to present fairly our financial position at April 30, 2021 and the results of our operations and cash flows for the periods presented. Interim results are subject to significant seasonal variations and the results of operations for the three months ended April 30,2021 are not necessarily indicative of the results to be expected for the full year. Reverse Stock Split On November 24, 2020, the Company filed a Certificate of Change with the Secretary of the State of Nevada to affect a 1-for-500 reverse stock split (the “Reverse Stock Split”). The Reverse Stock Split was formally processed by FINRA effective on February 25, 2021 and the Company’s common stock began trading on a split-adjusted basis on February 25, 2021. Prior to the effective date of the Certificate of Change, the Company was authorized to issue 6,150,000,000 shares of common stock. As a result of the Reverse Stock Split, the Company is authorized to issue 12,300,000 shares of common stock. The Reverse Stock Split did not have any effect on the stated par value of the common stock. Prior to the effective date of the Certificate of Change, the Company was authorized to issue 100,000,000 shares of Class A common stock. As a result of the Reverse Stock Split, the Company is authorized to issue 200,000 shares of Class A common stock. As of February 24, 2021 (immediately prior to the effective date of the Reverse Stock Split), there were 51,000,000 shares of Class A common stock outstanding. As a result of the Reverse Stock Split, there are approximately adjustment due to the effect of rounding fractional shares into whole shares). The Reverse Stock Split did not have any effect on the stated par value of the Class A common stock. All references to common shares and common share data in these consolidated financial statements and elsewhere in this Form 10-Q reflect the Reverse Stock Split.

Going Concern

Going Concern	3 Months Ended
	Apr. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	NOTE 2 – Going concern The Company has incurred losses from operations and requires additional funds for further exploratory activity and to maintain its claims prior to attaining a revenue generating status. There are no assurances that a commercially viable mineral deposit exists on any of our properties. In addition, the Company may not find sufficient ore reserves to be commercially mined. As such, there is substantial doubt about the Company’s ability to continue as a going concern. Management is working to secure additional funds through the exercise of stock warrants already outstanding, equity financings, debt financings or joint venture agreements. The consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Apr. 30, 2021
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	NOTE 3 – Summary of Significant Accounting Policies Fair Value ASC 820 Fair Value Measurements and Disclosures (“ASC 820”), defines fair value, establishes a framework for measuring fair value and enhances disclosures about fair value measurements. It defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value: Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities that are not active; and model-driven valuations whose inputs are observable or whose significant value drivers are observable. Valuations may be obtained from, or corroborated by, third-party pricing services. Level 3: Unobservable inputs to measure fair value of assets and liabilities for which there is little, if any market activity at the measurement date, using reasonable inputs and assumptions based upon the best information at the time, to the extent that inputs are available without undue cost and effort. Fair value measurements at reporting date using: Description Fair Value Quoted prices in Significant Significant Warrant and convertible note derivative liability at April 30, 2021 $ 290,293 - - $ 290,293 Warrant and convertible note derivative liability at January 31, 2021 $ - - - $ - Our financial instruments consist of cash and cash equivalents, prepaid expenses, accounts payable, accrued liabilities, notes payable, convertible notes payable, and derivative liability. It is management’s opinion that we are not exposed to significant interest, currency or credit risks arising from these financial instruments. With the exception of the derivative liability, the fair value of these financial instruments approximates their carrying values based on their short maturities or for long-term debt based on borrowing rates currently available to us for loans with similar terms and maturities. Gains and losses recognized on changes in estimated fair value of the derivative liability are reported in other income (expense) as gain (loss) on change in fair value of derivative liability.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Apr. 30, 2021
Related Party Transactions [Abstract]
Related Party Transactions	NOTE 4 – Related party transactions Our CEO, Brett Gross, was elected as President and Chief Executive Officer on December 7, 2018 and received no compensation for these services during the three months ended April 30,2021 and 2020. From October 2019 through April 30, 2021, our CEO, Brett Gross, made various payments on behalf of the Company totaling $161,977, and advanced the Company $62,000 in cash, all of which are reflected as advances from related party on the accompanying consolidated balance sheets. The total advances were $314,742 and $301,077 as of April 30, 2021 and January 31, 2021, respectively, bear no interest and have no specified repayment date. During the three months ended April 30, 2021, the note principal increased $5,000 for a payment by the director to a consultant on behalf of the Company. Total maturities of principal and accrued interest under all notes to two directors as of April 30, 2021 are $285,448 due July 31, 2021. The Company has a note payable of $10,000 from James Briscoe, under a promissory note dated September 17, 2018, which matured and became past due on September 17, 2019 with interest at 10%. As of April 30 and January 31, 2021, the total balance of all related party notes was $298,064 and $283,271, respectively, which includes accrued interest of $42,152 and $36,070, respectively. As of April 30 and January 31, 2021, we had a balance of accrued unpaid wages of $759,949 to James Briscoe, our former Chairman of the Board, CEO, Chief Geologist, Secretary, Treasurer, and President. Additionally, we had a balance of accrued unpaid wages of $15,625 to a former President and $36,137 to Patricia Madaris, VP Finance & CFO. As of April 30 and January 31, 2021, we had an aggregate balance due of approximately $167,000 on credit cards guaranteed by James Briscoe reflected in accounts payable and accrued liabilities on the accompanying consolidated balance sheets. As of April 30 and January 31, 2021, we had accounts payable to JABA (controlled by James Briscoe) of $34,798, which is reflected as accounts payable to related party on the accompanying consolidated balance sheets. As of April 30 and January 31, 2021, we had a balance of $16,321 due to the spouse of James Briscoe.

Stock Options

Stock Options	3 Months Ended
	Apr. 30, 2021
Share-based Payment Arrangement [Abstract]
Stock Options	NOTE 5 – Stock options Qualified and Non-qualified incentive stock options outstanding at April 30, 2021 are as follows: Weighted Number of exercise options price per share Outstanding, January 31, 2021 146,000 $ 3.019 Granted - - Expired - - Exercised - - Outstanding, April 30, 2021 146,000 $ 3.019 Exercisable, April 30, 2021 146,000 $ 3.019 These options had a weighted average remaining life of 7.37 years and an aggregate intrinsic value of $0 as of April 30, 2021. During the three months ended April 30, 2021 and 2020, we recognized $0 and $0, respectively, of compensation expense related to stock options.

Warrants

Warrants	3 Months Ended
	Apr. 30, 2021
Warrants and Rights Note Disclosure [Abstract]
Warrants	NOTE 6 – Warrants As of April 30, 2021, there were 449,281 purchase warrants outstanding and exercisable. The warrants have a weighted average remaining life of 2.1 years and a weighted average exercise price of $2.101 per warrant for one common share. The warrants had an aggregate intrinsic value of $40,764 as of April 30, 2021. Stock warrants outstanding at April 30, 2021 are as follows: Weighted average Number of warrants exercise Outstanding, January 31, 2021 400,166 $ 2.155 Issued 55,115 1.524 Expired - - Exercised (6,000 ) 0.350 Outstanding, April 30, 2021 449,281 $ 2.101 Exercisable, April 30, 2021 449,281 $ 2.101 During the three months ended April 30, 2021, the Company issued 55,115 warrants to investors as part of their purchase of common stock. The warrants have a three-year term and are exercisable at any time at exercise prices ranging from $1.426 to $1.646. As of June 17, 2021, the Company extended all warrants issued by the Company which expired or will expire during the year 2021. These warrants are extended for an additional three years. All other terms of the warrants remain unchanged, including application of the reverse split effective on February 25, 2021.

Derivative Liabilities

Derivative Liabilities	3 Months Ended
	Apr. 30, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Liabilities	NOTE 7 – Derivative Liabilities The embedded conversion feature in the convertible debt instruments that the Company issued (See Note 8), that became convertible during the three months ended April 30,2021, qualified it as a derivative instrument since the number of shares issuable under the note is indeterminate based on guidance in FASB ASC 815, Derivatives and Hedging. These convertible notes tainted all other equity linked instruments including outstanding warrants and fixed rate convertible debt on the date that the instrument became convertible. The valuation of the derivative liability of the warrants was determined through the use of a Monte Carlo options model that values the liability of the warrants based on a risk-neutral valuation where the price of the option is its discounted expected value. The technique applied generates a large number of possible (but random) price paths for the underlying common stock via simulation, and then calculates the associated exercise value (i.e. “payoff”) of the option for each path. These payoffs are then averaged and discounted to a current valuation date resulting in the fair value of the option. The valuation of the derivative liability attached to the convertible debt was arrived at through the use of a Monte Carlo model that values the derivative liability within the notes. The technique applied generates a large number of possible (but random) price paths for the underlying (or underlyings) via simulation, and then calculates the associated payment value (cash, stock, or warrants) of the derivative features. The price of the underlying common stock is modeled such that it follows a geometric Brownian motion with constant drift, and elastic volatility (increasing as stock price decreases). The stock price is determined by a random sampling from a normal distribution. Since the underlying random process is the same, for enough price paths, the value of the derivative is derived from path dependent scenarios and outcomes. The features in the notes that were analyzed and incorporated into the model included the conversion features with the reset provisions, the call/redemption/prepayment options, and the default provisions. Based on these features, there are six primary events that can occur; payments are made in cash; payments are made with stock; the note holder converts upon receiving a redemption notice; the note holder converts the note; the issuer redeems the note; or the Company defaults on the note. The model simulates the underlying economic factors that influenced which of these events would occur, when they were likely to occur, and the specific terms that would be in effect at the time (i.e. stock price, conversion price, etc.). Probabilities were assigned to each variable such as redemption likelihood, default likelihood, and timing and pricing of reset events over the remaining term of the notes based on management projections. This led to a cash flow simulation over the life of the note. A discounted cash flow for each simulation was completed, and it was compared to the discounted cash flow of the note without the embedded features, thus determining a value for the derivative liability. Key inputs and assumptions used to value the convertible note when it became convertible and upon settlement, and warrants upon tainting, were as follows: ● The stock projections are based on the historical volatilities for each date. These volatilities were in the 197.3% to 211.4% range. The stock price projection was modeled such that it follows a geometric Brownian motion with constant drift and a constant volatility, starting with the market stock price at each valuation date; ● An event of default would not occur during the remaining term of the note; ● Conversion of the notes to stock would be completed monthly after any holding period and would be limited based on: 5% of the last 6 months average trading volume and the ownership limit identified in the contract assuming the underlying number of common shares increases at 1% per month. ● The effective discount was determined based on the historical trading history of the Company based on the specific pricing mechanism in each note; ● The Company would not have funds available to redeem the notes during the remaining term of the convertible notes; ● Discount rates were based on risk free rates in effect based on the remaining term and date of each valuation and instrument. ● The Holder would exercise the warrant at maturity if the stock price was above the exercise price; ● The Holder would exercise the warrant after any holding period prior to maturity at target prices starting at 2 times the exercise price for the Warrants or higher subject to monthly limits of: 5% of the last 6 months average trading volume increasing by 1% per month and the ownership limit identified in the contract assuming the underlying number of common shares increases at 1% per month. Using the results from the model, the Company recorded a derivative liability during the three months ended April 30,2021 of $293,528 for newly granted and existing warrants (see Note 6) that were tainted and a derivative liability of $64,823 for the fair value of the convertible feature included in the Company’s convertible debt instruments. The derivative liability recorded for the convertible feature created a “day 1” derivative loss of $0 and a debt discount of $64,823 that was amortized over the remaining term of the note using the effective interest rate method. Interest expense related to the amortization of this debt discount for the three months ended April 30,2021, was $21,725. The remaining unamortized debt discount related to the derivative liability was $43,098 as of April 30, 2021. During the three months ended April 30,2021, the Company recorded a reclassification from derivative liability to equity of $0 for warrants becoming untainted and $17,406 due to the conversions of a portion of the Company’s convertible notes. The Company also recorded the change in the fair value of the derivative liability as a gain of $50,652 to reflect the value of the derivative liability for warrants and convertible notes as of April 30, 2021. During the three months ended April 30, 2020, the Company recorded a reclassification from derivative liability to equity of $0 for warrants becoming untainted and $106,514 due to the conversions of a portion of the Company’s convertible notes. The Company also recorded the change in the fair value of the derivative liability as a gain of $55,036 to reflect the value of the derivative liability for warrants and convertible notes as of April 30, 2020. The Company did not have a derivative liability as of January 31, 2021 since outstanding convertible notes were not convertible at period end or were fully converted during the period and consequently, the outstanding warrants were no longer tainted. The following table sets forth a reconciliation of changes in the fair value of the Company’s derivative liability: Three months ended April 30, 2021 2020 Beginning balance $ - $ - Total gains (50,652 ) (55,036 ) Settlements (17,406 ) (106,514 ) Additions recognized as debt discount 64,823 107,000 Additions due to tainted warrants 293,528 189,472 Ending balance $ 290,293 $ 134,922 Change in unrealized gain included in earnings relating to derivatives $ (50,652 ) $ (55,036 )

Long-term Debt and Convertible

Long-term Debt and Convertible Promissory Notes	3 Months Ended
	Apr. 30, 2021
Debt Disclosure [Abstract]
Long-term Debt and Convertible Promissory Notes	NOTE 8 – Long-term debt and convertible promissory notes Following is a summary of convertible promissory notes: April 30, 2021 January 31, 2021 8% convertible note payable issued October 2020, due September 2021 $ 72,546 $ 95,611 8% convertible note payable issued April 2021, due April 2022 63,055 - 135,601 95,611 Less debt discount (51,425 ) (7,642 ) Less current portion of convertible notes (84,176 ) (87,969 ) Long-term convertible notes payable $ - $ - On October 28, 2020, we received net proceeds of $82,000 from the issuance of a convertible note dated October 20, 2020 (the “October 2020 Note”). The note bears interest at 8%, includes OID of $8,500 and legal and due diligence fees of $3,000, matures on September 1, 2021, and is convertible after 180 days into shares of the Company’s common stock at a price of 75% of the average of the lowest 5 weighted average market price of the Company’s common stock during the 10 trading days prior to conversion. During the three months ended April 30, 2021, the noteholder converted a total of $27,000 of the note for 33,881 shares of the Company’s common stock, leaving a balance of $72,546 as of April 30, 2021. On April 26, 2021, we received net proceeds of $60,000 from the issuance of a convertible note dated April 23, 2021 (the “April 2021 Note”). The note bears interest at 8%, includes legal and due diligence fees of $3,000, matures on April 23, 2022, and is convertible after 180 days into shares of the Company’s common stock at a price of 75% of the average of the lowest 5 weighted average market price of the Company’s common stock during the 10 trading days prior to conversion. During the three months ended April 30, 2021 and 2020, the Company recorded debt discounts of $64,823 and 107,000, respectively, due to the derivative liabilities, and original issue debt discounts of $3,000 and $0, respectively, due to the convertible notes. The Company recorded amortization of these discounts of $23,306 and $98,568 for the three months ended April 30, 2021 and 2020, respectively. Notes Payable On June 22, 2020, the Company received loan proceeds of $32,300 (net of $100 loan fee) under the SBA’s Economic Injury Disaster Loan program (“EIDL”). The EIDL loan, dated June 16, 2020, bears interest at 3.75%, has a 30-year term, is secured by substantially all assets of the Company, and is due in monthly installments of $158 beginning June 18, 2021 (extended to June 18, 2023). On February 16, 2021, the Company received loan proceeds of $32,497 under the Payroll Protection Program (“PPP”). The PPP loan bears interest at 1%, has a 5-year term, and is due in equal monthly installments beginning December 16, 2021. The balance of these two notes total $66,020, including accrued interest of $1,123, and is included in long-term debt as of April 30, 2021.

Stockholders' Deficit

Stockholders' Deficit	3 Months Ended
	Apr. 30, 2021
Equity [Abstract]
Stockholders' Deficit	NOTE 9 – Stockholders’ deficit Common Stock Our undesignated common shares are all of the same class, are voting and entitle stockholders to receive dividends as defined. Upon liquidation or wind-up, stockholders are entitled to participate equally with respect to any distribution of net assets or any dividends that may be declared. On March 5, 2021, the Company issued 6,000 shares of its common stock to an accredited investor for the exercise of warrants for proceeds of $2,100, or $0.35 per common share. On March 26, 2021, the Company issued 17,006 shares of its common stock and 8,503 warrants to our CEO for gross proceeds of $20,000, for $1.176 per unit. The warrants have a three-year term and are exercisable at any time at an exercise price of $1.646. In March 2021, the Company issued 49,412 shares of its common stock and 24,706 warrants to our CEO for gross proceeds of $55,000 for $1.113 per unit. The warrants have a three-year term and are exercisable at any time at an exercise price of $1.558. On April 2, 2021, the Company issued 9,818 shares of its common stock and 4,909 warrants to an accredited investor for gross proceeds of $10,000, or $1.019 per unit. The warrants have a three-year term and are exercisable at any time at an exercise price of $1.426. On April 23, 2021, the Company issued 15,049 of its common stock to a noteholder for the conversion of $12,000 of principal under the October 2020 Note, or $0.797 per share. On April 27, 2021, the Company issued 18,832 of its common stock to a noteholder for the conversion of $15,000 of principal under the October 2020 Note, or $0.797 per share. On April 30, 2021, the Company received proceeds of $20,000 from an investor for the purchase of 19,268 shares of its common stock and 9,634 warrants, at a price of $1.038 per unit. The warrants have a three-year term and are exercisable at any time at an exercise price of $1.453. Reverse Stock Split On November 24, 2020, the Company filed a Certificate of Change with the Secretary of the State of Nevada to affect a 1-for-500 reverse stock split (the “Reverse Stock Split”). The Reverse Stock Split was formally processed by FINRA effective on February 25, 2021 and the Company’s common stock began trading on a split-adjusted basis on February 25, 2021. Prior to the effective date of the Certificate of Change, the Company was authorized to issue 6,150,000,000 shares of common stock. As a result of the Reverse Stock Split, the Company is authorized to issue 12,300,000 shares of common stock. The Reverse Stock Split did not have any effect on the stated par value of the common stock. Prior to the effective date of the Certificate of Change, the Company was authorized to issue 100,000,000 shares of Class A common stock. As a result of the Reverse Stock Split, the Company is authorized to issue 200,000 shares of Class A common stock, with 102,000 shares of Class A common stock outstanding. As a result of the Reverse Stock Split, there was an adjustment of approximately 2,408 common shares due to the effect of rounding fractional shares into whole shares. The Reverse Stock Split did not have any effect on the stated par value of the Class A common stock. All references to common shares and common share data in these unaudited consolidated financial statements and elsewhere in this Form 10-Q as of April 30, 2021, and for the three months ended April 30, 2021 and 2020, reflect the Reverse Stock Split.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Apr. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 10 – Commitments and contingencies Legal Matter On August 22, 2019 (and amended on December 23, 2019), the Company filed a complaint with the Superior Court of Arizona (Case No. C20194139), demanding the titles and possession of certain vehicles and equipment of the Company from our former CEO, as well as seeking recovery of damages from the former CEO in an amount of not less than $50,000. None of the vehicles and equipment, individually or in total, have any material net book value (being fully depreciated) as of April 30, 2021 or January 31, 2021. The matter is ongoing as of the date of this filing. On February 18, 2020, our former CEO and his spouse (the “Counterclaimants”) filed a First Amended Answer: First Amended Complaint and Counterclaim with the Superior Court of Arizona seeking dismissal of the Company’s complaint and reimbursement of Counterclaimants’ attorney fees incurred related to the matter. Additionally, the counterclaim alleges breach of contract by the Company and requests reimbursement of amounts loaned to the Company by our former CEO and his spouse, along with reimbursement of attorney fees. The Company believes these counterclaims are without merit and is aggressively defending them, and believes no unfavorable outcome or material effect on our consolidated financial statements will result.

Subsequent Events

Subsequent Events	3 Months Ended
	Apr. 30, 2021
Subsequent Events [Abstract]
Subsequent Events	NOTE 11 – Subsequent events In May 2021, the Company issued a total of 98,472 shares of its comm stock to a noteholder for the conversion of an aggregate of $69,900 of principal and accrued interest under the October 2020 Note, at prices ranging from $0.699 to $0.743 per share. On May 11, 2021, we issued a convertible note in the aggregate principal amount of $53,000 (the “May 2021 Note”). The note bears interest at 8%, matures on May 11, 2022, and is convertible after 180 days into shares of the Company’s common stock at a price of 75% of the average of the lowest 5 weighted average market price of the Company’s common stock during the 10 trading days prior to conversion. As of June 17, 2021, the Company extended all warrants issued by the Company which expired or will expire during the year 2021. These warrants are extended for an additional three years. All other terms of the warrants remain unchanged, including application of the reverse split effective on February 25, 2021.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Apr. 30, 2021
Accounting Policies [Abstract]
Fair Value	Fair Value ASC 820 Fair Value Measurements and Disclosures (“ASC 820”), defines fair value, establishes a framework for measuring fair value and enhances disclosures about fair value measurements. It defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value: Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities that are not active; and model-driven valuations whose inputs are observable or whose significant value drivers are observable. Valuations may be obtained from, or corroborated by, third-party pricing services. Level 3: Unobservable inputs to measure fair value of assets and liabilities for which there is little, if any market activity at the measurement date, using reasonable inputs and assumptions based upon the best information at the time, to the extent that inputs are available without undue cost and effort. Fair value measurements at reporting date using: Description Fair Value Quoted prices in Significant Significant Warrant and convertible note derivative liability at April 30, 2021 $ 290,293 - - $ 290,293 Warrant and convertible note derivative liability at January 31, 2021 $ - - - $ - Our financial instruments consist of cash and cash equivalents, prepaid expenses, accounts payable, accrued liabilities, notes payable, convertible notes payable, and derivative liability. It is management’s opinion that we are not exposed to significant interest, currency or credit risks arising from these financial instruments. With the exception of the derivative liability, the fair value of these financial instruments approximates their carrying values based on their short maturities or for long-term debt based on borrowing rates currently available to us for loans with similar terms and maturities. Gains and losses recognized on changes in estimated fair value of the derivative liability are reported in other income (expense) as gain (loss) on change in fair value of derivative liability.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Apr. 30, 2021
Accounting Policies [Abstract]
Schedule of Fair Value of Financial Instruments	Fair value measurements at reporting date using: Description Fair Value Quoted prices in Significant Significant Warrant and convertible note derivative liability at April 30, 2021 $ 290,293 - - $ 290,293 Warrant and convertible note derivative liability at January 31, 2021 $ - - - $ -

Stock Options (Tables)

Stock Options (Tables)	3 Months Ended
	Apr. 30, 2021
Share-based Payment Arrangement [Abstract]
Schedule of Stock Options Activity	Qualified and Non-qualified incentive stock options outstanding at April 30, 2021 are as follows: Weighted Number of exercise options price per share Outstanding, January 31, 2021 146,000 $ 3.019 Granted - - Expired - - Exercised - - Outstanding, April 30, 2021 146,000 $ 3.019 Exercisable, April 30, 2021 146,000 $ 3.019

Warrants (Tables)

Warrants (Tables)	3 Months Ended
	Apr. 30, 2021
Warrants and Rights Note Disclosure [Abstract]
Schedule of Stock Warrants Outstanding	Stock warrants outstanding at April 30, 2021 are as follows: Weighted average Number of warrants exercise Outstanding, January 31, 2021 400,166 $ 2.155 Issued 55,115 1.524 Expired - - Exercised (6,000 ) 0.350 Outstanding, April 30, 2021 449,281 $ 2.101 Exercisable, April 30, 2021 449,281 $ 2.101

Derivative Liabilities (Tables)

Derivative Liabilities (Tables)	3 Months Ended
	Apr. 30, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Changes in Fair Value of Derivative Liabilities	The following table sets forth a reconciliation of changes in the fair value of the Company’s derivative liability: Three months ended April 30, 2021 2020 Beginning balance $ - $ - Total gains (50,652 ) (55,036 ) Settlements (17,406 ) (106,514 ) Additions recognized as debt discount 64,823 107,000 Additions due to tainted warrants 293,528 189,472 Ending balance $ 290,293 $ 134,922 Change in unrealized gain included in earnings relating to derivatives $ (50,652 ) $ (55,036 )

Long-term Debt and Convertibl_2

Long-term Debt and Convertible Promissory Notes (Tables)	3 Months Ended
	Apr. 30, 2021
Debt Disclosure [Abstract]
Summary of Convertible Promissory Notes	Following is a summary of convertible promissory notes: April 30, 2021 January 31, 2021 8% convertible note payable issued October 2020, due September 2021 $ 72,546 $ 95,611 8% convertible note payable issued April 2021, due April 2022 63,055 - 135,601 95,611 Less debt discount (51,425 ) (7,642 ) Less current portion of convertible notes (84,176 ) (87,969 ) Long-term convertible notes payable $ - $ -

Basis of Presentation (Details

Basis of Presentation (Details Narrative) - shares	3 Months Ended
	Apr. 30, 2021	Mar. 31, 2021	Feb. 24, 2021	Jan. 31, 2021	Nov. 24, 2020	Nov. 23, 2020
Reverse stock split description	On November 24, 2020, the Company filed a Certificate of Change with the Secretary of the State of Nevada to affect a 1-for-500 reverse stock split (the "Reverse Stock Split"). The Reverse Stock Split was formally processed by FINRA effective on February 25, 2021 and the Company's common stock began trading on a split-adjusted basis on February 25, 2021.	On November 24, 2020, the Company filed a Certificate of Change with the Secretary of the State of Nevada to affect a 1-for-500 reverse stock split (the "Reverse Stock Split").
Common stock, shares authorized	12,300,000			12,300,000	12,300,000	6,150,000,000
Common stock, shares outstanding	10,052,163			9,902,052
Class A Common Stock [Member]
Common stock, shares authorized	200,000			0	200,000	100,000,000
Common stock, shares outstanding	102,000		51,000,000	0	102,000

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Schedule of Fair Value of Financial Instruments (Details) - USD ($)	Apr. 30, 2021	Jan. 31, 2021
Warrant and convertible note derivative liability	$ 290,293
Fair Value, Inputs, Level 1 [Member]
Warrant and convertible note derivative liability
Fair Value, Inputs, Level 2 [Member]
Warrant and convertible note derivative liability
Fair Value, Inputs, Level 3 [Member]
Warrant and convertible note derivative liability	$ 290,293

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	Sep. 17, 2018	Apr. 30, 2021	Apr. 30, 2021	Jan. 31, 2021
Related Party Transaction [Line Items]
Due to related party		$ 298,064	$ 298,064	$ 283,271
Advances from related party		314,742	314,742	301,077
Notes payable to related party		298,064	298,064	283,271
Accrued interest		42,152	42,152	36,070
Accrued unpaid wages		811,711	811,711	811,711
James Briscoe [Member]
Related Party Transaction [Line Items]
Debt instrument, interest rate	10.00%
Debt instrument, maturity date	Sep. 17, 2019
Notes payable to related party	$ 10,000
Accrued unpaid wages		759,949	759,949	759,949
James Briscoe [Member] | Accounts Payable and Accrued Liabilities [Member]
Related Party Transaction [Line Items]
Due to related party		167,000	167,000	167,000
James Briscoe [Member] | Accounts Payable [Member]
Related Party Transaction [Line Items]
Due to related party		34,798	34,798	34,798
Former President [Member]
Related Party Transaction [Line Items]
Accrued unpaid wages		15,625	15,625	15,625
Patricia Madaris, CFO [Member]
Related Party Transaction [Line Items]
Accrued unpaid wages		36,137	36,137	36,137
Spouse of James Briscoe [Member]
Related Party Transaction [Line Items]
Due to related party		16,321	16,321	$ 16,321
CEO [Member]
Related Party Transaction [Line Items]
Due to related party		161,977	161,977
Advances from related party		62,000	62,000
Director [Member] | Promissory Note [Member]
Related Party Transaction [Line Items]
Debt instrument, interest rate				10.00%
Increase in debt principal amount			5,000
Two Directors [Member] | Promissory Note [Member]
Related Party Transaction [Line Items]
Due to related party		$ 285,448	$ 285,448
Debt instrument, maturity date		Jul. 31, 2021

Stock Options (Details Narrativ

Stock Options (Details Narrative) - USD ($)	3 Months Ended
	Apr. 30, 2021	Apr. 30, 2020
Share-based Payment Arrangement [Abstract]
Weighted average remaining life, stock options	7 years 4 months 13 days
Stock options, aggregate intrinsic value	$ 0
Compensation expense	$ 0	$ 0

Stock Options - Schedule of Sto

Stock Options - Schedule of Stock Options Activity (Details)	3 Months Ended
	Apr. 30, 2021$ / sharesshares
Share-based Payment Arrangement [Abstract]
Number of options, Outstanding | shares	146,000
Number of options, Granted | shares
Number of options, Expired | shares
Number of options, Exercised | shares
Number of options, Outstanding | shares	146,000
Number of options, Exercisable | shares	146,000
Weighted average exercise price per share, Outstanding | $ / shares	$ 3.019
Weighted average exercise price per share, Granted | $ / shares
Weighted average exercise price per share, Expired | $ / shares
Weighted average exercise price per share, Exercised | $ / shares
Weighted average exercise price per share, Outstanding | $ / shares	3.019
Weighted average exercise price per share, Exercisable | $ / shares	$ 3.019

Warrants (Details Narrative)

Warrants (Details Narrative) - USD ($)	Jul. 17, 2021	Apr. 30, 2021	Jan. 31, 2021	Apr. 30, 2020
Warrants [Line Items]
Share purchase warrants outstanding and exercisable		449,281
Warrants weighted average remaining life		2 years 1 month 6 days
Weighted average exercise price of warrant		$ 2.101
Weighted average intrinsic value for warrants outstanding		$ 40,764
Warrant [Member]
Warrants [Line Items]
Weighted average exercise price of warrant			$ 2.101
Subsequent Event [Member] | Warrant [Member]
Warrants [Line Items]
Warrant expiration term description	The Company extended all warrants issued by the Company which expired or will expire during the year 2021. These warrants are extended for an additional three years. All other terms of the warrants remain unchanged, including application of the reverse split effective on February 25, 2021.
Investor [Member]
Warrants [Line Items]
Number of warrants issued		55,115
Warrants terms		3 years
Investor [Member] | Minimum [Member]
Warrants [Line Items]
Warrant exercise price per share				$ 1.426
Investor [Member] | Maximum [Member]
Warrants [Line Items]
Warrant exercise price per share				$ 1.646

Warrants - Schedule of Stock Wa

Warrants - Schedule of Stock Warrants Outstanding (Details) - Warrant [Member]	3 Months Ended
	Apr. 30, 2021$ / sharesshares
Warrants [Line Items]
Number of warrants, Outstanding | shares	400,166
Number of warrants, Issued | shares	55,115
Number of warrants, Expired | shares
Number of warrants, Exercised | shares	(6,000)
Number of warrants, Outstanding | shares	449,281
Number of warrants, Exercisable | shares	449,281
Weighted average exercise price, Outstanding | $ / shares	$ 2.155
Weighted average exercise price, Issued | $ / shares	1.524
Weighted average exercise price, Expired | $ / shares
Weighted average exercise price, Exercised | $ / shares	0.350
Weighted average exercise price, Outstanding | $ / shares	2.101
Weighted average exercise price, Exercisable | $ / shares	$ 2.101

Derivative Liabilities (Details

Derivative Liabilities (Details Narrative)	3 Months Ended
	Apr. 30, 2021USD ($)	Apr. 30, 2020USD ($)	Jan. 31, 2021USD ($)
Unamortized debt discount	$ 3,000	$ 0
Derivative Liability [Member]
Conversion note description	Conversion of the notes to stock would be completed monthly after any holding period and would be limited based on: 5% of the last 6 months average trading volume and the ownership limit identified in the contract assuming the underlying number of common shares increases at 1% per month.
Percentage of exercise price for warrant, description	The Holder would exercise the warrant after any holding period prior to maturity at target prices starting at 2 times the exercise price for the Warrants or higher subject to monthly limits of: 5% of the last 6 months average trading volume increasing by 1% per month and the ownership limit identified in the contract assuming the underlying number of common shares increases at 1% per month.
Derivative loss	$ 0
Amortization of debt discount	64,823
Interest expense	21,725
Unamortized debt discount			$ 43,098
Reclassification of derivative liability to equity	0	0
Reclassification due to conversion of convertible notes	17,406	106,514
Gain on derivative liability	50,652	$ 55,036
Derivative Liability [Member] | Convertible Debt [Member]
Derivative liabilities	64,823
Derivative Liability [Member] | Warrant [Member]
Derivative liabilities	$ 293,528
Measurement Input, Price Volatility [Member] | Minimum [Member]
Fair value assumptions, measurement input, percentages	197.3
Measurement Input, Price Volatility [Member] | Maximum [Member]
Fair value assumptions, measurement input, percentages	211.4

Derivative Liabilities - Schedu

Derivative Liabilities - Schedule of Changes in Fair Value of Derivative Liabilities (Details) - USD ($)	3 Months Ended
	Apr. 30, 2021	Apr. 30, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Beginning balance
Total gains	(50,652)	(55,036)
Settlements	(17,406)	(106,514)
Additions recognized as debt discount	64,823	107,000
Additions due to tainted warrants	293,528	189,472
Ending balance	290,293	134,922
Change in unrealized gain included in earnings relating to derivatives	$ (50,652)	$ (55,036)

Long-term Debt and Convertibl_3

Long-term Debt and Convertible Promissory Notes (Details Narrative)	Apr. 27, 2021USD ($)shares	Apr. 26, 2021USD ($)TradingInteger	Apr. 23, 2021USD ($)shares	Feb. 16, 2021USD ($)	Oct. 28, 2020USD ($)TradingInteger	Jun. 22, 2020USD ($)	Apr. 30, 2021USD ($)shares	Apr. 30, 2020USD ($)
Debt Instrument [Line Items]
Net proceeds from debt							$ 60,000
Legal fees							19,947	50,536
Debt discounts amount							64,823	107,000
Original issue discount amount							3,000	0
Amortization of debt discount							23,306	$ 98,568
Debt including interest							66,020
Debt principal							1,123
SBA's Economic Injury Disaster Loan Program [Member]
Debt Instrument [Line Items]
Debt instrument, maturity date						Jun. 18, 2021
Proceeds from loan						$ 32,300
Loan fee						$ 100
Loan, interest rate						3.75%
Debt term						30 years
Loan installment due amount						$ 158
SBA's Economic Injury Disaster Loan Program [Member] | Extended Maturity [Member]
Debt Instrument [Line Items]
Debt instrument, maturity date						Jun. 18, 2023
PPP Loan [Member]
Debt Instrument [Line Items]
Debt instrument, maturity date				Dec. 16, 2021
Proceeds from loan				$ 32,497
Loan, interest rate				1.00%
Debt term				5 years
October 2020 Note [Member]
Debt Instrument [Line Items]
Net proceeds from debt					$ 82,000
Debt instrument interest rate					8.00%
Legal fees					$ 3,000
Debt instrument, maturity date					Sep. 1, 2021
Debt instrument convertible consecutive trading days | Integer					180
Common stock conversion price per share					75.00%
Debt instrument, convertible, threshold trading days | Trading					10
Debt instrument conversion, amount	$ 15,000		$ 12,000				$ 27,000
Debt conversion on convertible shares | shares	18,832		15,049				33,881
Principal and interest total amount							$ 72,546
Original issue discount amount					$ 8,500
April 2021 Note [Member]
Debt Instrument [Line Items]
Net proceeds from debt		$ 60,000
Debt instrument interest rate		8.00%
Legal fees		$ 3,000
Debt instrument, maturity date		Apr. 23, 2022
Debt instrument convertible consecutive trading days | Integer		180
Common stock conversion price per share		75.00%
Debt instrument, convertible, threshold trading days | Trading		10

Long-term Debt and Convertibl_4

Long-term Debt and Convertible Promissory Notes - Summary of Convertible Promissory Notes (Details) - USD ($)	Apr. 30, 2021	Jan. 31, 2021
Debt Instrument [Line Items]
Convertible note payable	$ 135,601	$ 95,611
Less debt discount	(51,425)	(7,642)
Less current portion of convertible notes	(84,176)	(87,969)
Long-term convertible notes payable
Convertible Debt One [Member]
Debt Instrument [Line Items]
Convertible note payable	72,546	95,611
Convertible Debt Two [Member]
Debt Instrument [Line Items]
Convertible note payable	$ 63,055

Long-term Debt and Convertibl_5

Long-term Debt and Convertible Promissory Notes - Summary of Convertible Promissory Notes (Details) (Parenthetical)	3 Months Ended	12 Months Ended
	Apr. 30, 2021	Jan. 31, 2021
Convertible Debt One [Member]
Convertible notes payable, interest rate	8.00%	8.00%
Debt issuance date	Oct. 31, 2020	Oct. 31, 2020
Due date	Sep. 30, 2021	Sep. 30, 2021
Convertible Debt Two [Member]
Convertible notes payable, interest rate	8.00%	8.00%
Debt issuance date	Apr. 30, 2021	Apr. 30, 2021
Due date	Apr. 30, 2022	Apr. 30, 2022

Stockholders' Deficit (Details

Stockholders' Deficit (Details Narrative) - USD ($)	Apr. 27, 2021	Apr. 23, 2021	Apr. 02, 2021	Mar. 26, 2021	Mar. 05, 2021	Apr. 30, 2021	Mar. 31, 2021	Apr. 30, 2021	Mar. 31, 2021	Feb. 24, 2021	Jan. 31, 2021	Nov. 24, 2020	Nov. 23, 2020
Subsequent Event [Line Items]
Reverse stock split description								On November 24, 2020, the Company filed a Certificate of Change with the Secretary of the State of Nevada to affect a 1-for-500 reverse stock split (the "Reverse Stock Split"). The Reverse Stock Split was formally processed by FINRA effective on February 25, 2021 and the Company's common stock began trading on a split-adjusted basis on February 25, 2021.	On November 24, 2020, the Company filed a Certificate of Change with the Secretary of the State of Nevada to affect a 1-for-500 reverse stock split (the "Reverse Stock Split").
Common stock, shares authorized						12,300,000		12,300,000			12,300,000	12,300,000	6,150,000,000
Common stock, shares outstanding						10,052,163		10,052,163			9,902,052
Class A Common Stock [Member]
Subsequent Event [Line Items]
Common stock, shares authorized						200,000		200,000			0	200,000	100,000,000
Common stock, shares outstanding						102,000		102,000		51,000,000	0	102,000
Number of shares rounded due to reverse stock split												2,408
October 2020 Note [Member]
Subsequent Event [Line Items]
Proceeds from issuance of warrants						$ 20,000
Shares issued price per unit	$ 0.797	$ 0.797				$ 1.038		$ 1.038
Warrants term						3 years		3 years
Warrant exercise price per share						$ 1.453		$ 1.453
Debt conversion of convertible shares	18,832	15,049						33,881
Debt instrument conversion, amount	$ 15,000	$ 12,000						$ 27,000
October 2020 Note [Member] | Common Stock [Member]
Subsequent Event [Line Items]
Number of common stock shares issued						19,268
October 2020 Note [Member] | Warrant [Member]
Subsequent Event [Line Items]
Number of common stock shares issued						9,634
CEO [Member]
Subsequent Event [Line Items]
Number of common stock shares issued				17,006
Proceeds from issuance of warrants				$ 20,000
Shares issued price per unit				$ 1.176
Warrants purchase				8,503
Warrants term				3 years
Warrant exercise price per share				$ 1.646
CEO [Member] | Common Stock [Member]
Subsequent Event [Line Items]
Number of common stock shares issued							49,412
Proceeds from issuance of warrants							$ 55,000
Shares issued price per unit							$ 1.113		$ 1.113
Warrants purchase							24,706		24,706
Warrants term							3 years		3 years
Warrant exercise price per share							$ 1.558		$ 1.558
Accredited Investor [Member]
Subsequent Event [Line Items]
Number of common stock shares issued			9,818		6,000
Proceeds from issuance of warrants			$ 10,000		$ 2,100
Shares issued price per unit			$ 1.019		$ 0.35
Warrants purchase			4,909
Warrants term			3 years
Warrant exercise price per share			$ 1.426

Commitments and Contingencies (

Commitments and Contingencies (Details Narrative)	Aug. 22, 2019USD ($)
Former Chief Executive Officer [Member]
Loss contingency damages sought value	$ 50,000

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - USD ($)	May 11, 2021	Apr. 27, 2021	Apr. 23, 2021	Oct. 28, 2020	May 31, 2021	Apr. 30, 2021
October 2020 Note [Member]
Shares issued for conversion of debt		18,832	15,049			33,881
Debt conversion, converted instrument amount		$ 15,000	$ 12,000			$ 27,000
Debt instrument, interest rate				8.00%
Debt, maturity date				Sep. 1, 2021
Subsequent Event [Member] | October 2020 Note [Member]
Shares issued for conversion of debt					98,472
Debt conversion, converted instrument amount					$ 69,900
Subsequent Event [Member] | October 2020 Note [Member] | Minimum [Member]
Share price					$ 0.699
Subsequent Event [Member] | October 2020 Note [Member] | Maximum [Member]
Share price					$ 0.743
Subsequent Event [Member] | May 2021 Note [Member]
Debt instrument, face value	$ 53,000
Debt instrument, interest rate	8.00%
Debt, maturity date	May 11, 2022
Debt conversion, description	Convertible after 180 days into shares of the Company's common stock at a price of 75% of the average of the lowest 5 weighted average market price of the Company's common stock during the 10 trading days prior to conversion.